Table 2 Clinical data of published CIRC tumors
Case No. | Diagnosis | Complication (malignancy) | Age | Sex | Nodal / Extranodal | Region | Size | Treatment | Outcome | References |
|---|---|---|---|---|---|---|---|---|---|---|
1 | CIRC tumor | 57 | M | Nodal | Left hilum | NA | A left thoracotomy Radiotherapy; 50 Gy | Alive and well, 9 years | Eur J Cancer 1990; 26: 1121–6 | |
2 | CIRC tumor | 44 | M | Nodal | Left hilum | 4 cm | A left thoracotomy | Alive and well, over 3 years | ||
3 | CIRC tumor | 61 | M | Nodal | Right hilum | NA | A right thoracotomy Radiotherapy; 50 Gy | Alive and well, 13 months | ||
4 | CIRC tumor | 21 | F | Nodal | Mediastinal (superior) | 2.5 cm | CHOP chemotherapy Radiotherapy; 21 Gy VP-16 and CBDCA chemotherapy | Died of disease, 9 months | Am J Surg Pathol 2000; 24: 107–16 | |
5 | CIRC tumor | 73 | F | Extranodal | Right proximal forearm | NA | Surgery (excision) | NA | ||
6 | CIRC tumor | 62 | M | Nodal | Mediastinal (posterior) | 7.4 cm | Radiotherapy; 65 Gy | NA | ||
7 | CIRC tumor | 66 | M | Nodal | Submandibular | 1.5 cm | Surgery (excision) Radiotherapy | Alive and well, 12 months | Histopathology 2003; 43: 491–4 | |
8 | FRC tumor (primary) | 70 | F | Nodal | Right submandibular | 3.0 cm | Surgery | Died of disease, 10 months | Histopathology 2003; 43: 583–91 | |
CIRC tumor (relapse) | Nodal | Local relapse | 9.0 cm | VACOP B chemotherapy Two cycles of CNOP chemotherapy | ||||||
9 | CIRC tumor | Rectal adenocarcinoma | 62 | M | Extranodal | Spleen | 0.9 cm | Surgery (low anterior resection, splenectomy) | Alive and well, 2 years | Int J Surg Pathol 2014; 22: 447–50 |
10 | CIRC tumor with FDC features | 54 | F | Nodal | Right axillary | NA | Surgery (excision) | Alive and well, 2.5 years | Am J Surg Pathol 2015; 39: 573–80 | |
11 | CIRC tumor | Uterine endometrioid carcinoma | 67 | F | Nodal | Pelvic | 3.5 cm | Surgery (hysterectomy, bilateral adnexectomy, pelvic lymphadenectomy) | Alive and well, 9 months | Hum Pathol 2016; 49: 15–21 |
12 | Current case (primary) | 75 | M | Nodal | Mediastinal (superior) | 2.7 cm | Surgery (excision) CBDCA and DOC chemotherapy | Died of disease, 29 months | ||
Current case (relapse) | Small cell lung carcinoma Prostatic latent carcinoma | Extranodal | Right lung apex to the clavicle fossa | 1.5 cm | CDDP and VP-16 chemotherapy Three cycles of NGT chemotherapy Radiotherapy; 30 Gy |